Prognostic value of serum angiogenic activity in colorectal cancer patients

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 1, 2007, Pages 120-128

  Gonzalez, Francisco Jesus ^a   Quesada, Ana Rodriguez ^b   Sevilla, Isabel ^a   Baca, Juan Javier ^a   Medina, Miguel Angel ^b   Amores, Jose ^c   Diaz, Juan Miguel ^a   Rius Diaz, Francisca ^d   Marques, Eduardo ^a   Alba, Emilio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c HOSPITAL COSTA DEL SOL   (Spain)

^d UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

Angiogenesis; Angiogenic activity; Colorectal cancer; HUVEC; Prognostic; VEGF

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BLOOD; CARCINOMA; CASE CONTROL STUDY; CELL CULTURE; CELL PROLIFERATION; COLORECTAL TUMOR; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; SURVIVAL; TIME; TREATMENT OUTCOME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADULT; AGED; ANGIOGENESIS INDUCING AGENTS; CARCINOMA; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; COLORECTAL NEOPLASMS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BOVINAE;

EID: 33947317436     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00005.x     Document Type: Article

References (27)

1. Folkman J.Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1: 27-31.
2. Liekens S, De Clerk E, Neyst J. Angiogenesis: regulators and clinical applications.Biochem Pharmacol. 2001; 61: 253-70.
3. Lee JC, Chow NH, Wang ST, Huang SM. Prognostic values of vascular endothelial growth factor expression in colorectal cancer patients.Eur J Cancer 2000; 36: 748-53.
4. Papamichael D. Prognostic role of angiogenesis in colorectal cancer. Anticancer Res, 2001; 21: 4349-54.
5. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM. Vessel counts and expression of vascular endothelial growth factors as prognostic factors in node-negative colon cancer.Arch Surg. 1997; 132: 541-6.
6. Davies MM, Jonas SK, Kaur S, Allen-Mersh TG. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume.Br J Cancer. 2000; 82: 1004-8.
7. Werther K, Christensen U, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.Br J Cancer. 2002; 86: 417-23.
8. George ML, Tutton MG, Abulafi AM, Eccles SA, Swift RI. Plasma basic fibroblast growth factor levels in colorectal cancer: a clinically useful assay? Clin Exp Metastasis. 2002; 19: 735-8.
9. Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.Anticancer Res. 2002; 22: 2437-42.
10. Morelli D, Lazzerini D, Cazzaniga S, Squiccianiri P, Bignami P, Maier AM, Sfondrini L, Menard S, Colnaghi Ml, Balsari A. Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers.Clin Cancer Res. 1998; 4: 1221-4.
11. Balsari A, Maier JAM, Colnaghi Ml, Menard S. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma.Lab Invest. 1999; 79: 897-902.
12. Beecken WD, Bentas W, Glienke W, Linneweber J, Jonas D, Binder J, Kramer W. Serum angiogenic activity: diagnostic relevance in renal cell carcinoma.Eur Urol. 2002; 42: 364-9.
13. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures.J Cell Biol. 1988; 107: 1589-98.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods.1983; 65: 55-63.
15. Frank RE, Saclarides TJ, Leurgans S, Speziale N J, Drab EA, Rubin DB. Tumor angiogenesis as a predictor of recurrence and survival in patients with nodenegative colon cancer.Ann Surg. 1995; 222: 695-9.
16. Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY. Microvessel density and VEGF expression are prognostic factors in colorectal cancer.Meta-analysis of the literature. Br J Cancer 2006; 94: 1823-32.
17. Ferroni P, Spila A, Martini F, D'Alessandro R, Mariotti S, Del Monte G, Graciano P, Buonomo O, Guadagni F, Roselli M. Prognostic value of vascular endotelial growth factor tumor tissue content of colorectal cancer.Oncology. 2005; 69: 145-53.
18. Kang SM, Maeda K, Chung YS. Vascular endothelial growth factor statement correlates with hematogenous metastasis and prognosis in colorectal carcinoma.Oncol Rep. 1997; 4: 381-4.
19. Maeda K, Nishiguchi Y, Yashiro M, Yamada S, Onoda N, Sawada T, Kang SM, Hirakawa K. Expression of vascular endothelial growth factor and thrombospondin1 in colorectal carcinoma.Int J Mol Med. 2000; 5: 373-8.
20. Graziano F, Catalano V, Baldelii AM, Cascinu S. Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.Expert Rev Anticancer Ther. 2001; 1: 247-57.
21. Kumar H, Heer K, Lee PW, Duthie GS, MacDonald AW, Greenman J, Kerin MJ, Monson JR. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer.Clin Cancer Res. 1998; 4: 1279-85.
22. Takeda A, Shimada H, Imaseki H, Okazumi S, Natsume T, Suzuki T, Ochiai T. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers.Oncol Rep. 2000; 7: 333-8.
23. Karayiannakis AJ, Syrigos KN, Zbar A, Baibas N, Polychronidis A, Simopoulos C, Karatzas G. Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery.Surgery. 2002; 131: 548-55.
24. Beecken WD, Engl T, Hofmann J, Jonas D, Blatheda R. Clinical relevance of serum angiogenic activity in patients with transitional cell carcinoma of the bladder.J Cell Mol Med. 2005; 9: 655-61.
25. George ML, Dzik-Jurasz AS, Padhani AR, Brown G, Tait DM, Eccles SA, Swift RI. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer.Br J Surg. 2001; 88: 1628-36.
26. Bondestam J, Salven P, Jaaskela-Saari H, Ikonen T, Lepantalo M, Mattila S, Joensuu H. Major surgery increases serum levels of vascular endothelial growth factor only temporarily.Am J Surg. 2000; 179: 57-9.
27. Bagley RG, Walter-Yohrling J, Cao X, Weber W, Simons B, Cook BP, Chartrand SD, Wang C, Madden SL, Teicher BA. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells.Cancer Res. 2003; 63: 5866-73.